K-ras mutations and cetuximab in colorectal cancer.

^*Corresponding author for this work

Research output: Contribution to journal › Communication

9 Citations (Web of Science)

Original language	English
Journal	New England Journal of Medicine
DOIs	https://doi.org/10.1056/NEJMc082346
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d3b003237837456a9c07752e6576ddee,

title = "K-ras mutations and cetuximab in colorectal cancer.",

author = "Stefan Gattenl{\"o}hner and C Germer and HK Muller-Hermelink",

year = "2009",

doi = "10.1056/NEJMc082346",

language = "English",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

}

TY - JOUR

T1 - K-ras mutations and cetuximab in colorectal cancer.

AU - Germer, C

AU - Muller-Hermelink, HK

A2 - Gattenlöhner, Stefan

PY - 2009

Y1 - 2009

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000263411300026

UR - https://pubmed.ncbi.nlm.nih.gov/19238678

U2 - 10.1056/NEJMc082346

DO - 10.1056/NEJMc082346

M3 - Communication

C2 - 19238678

SN - 0028-4793

JO - New England Journal of Medicine

JF - New England Journal of Medicine

ER -